118 related articles for article (PubMed ID: 9917523)
1. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma.
Nishi T; Kuratsu J; Takeshima H; Saito Y; Kochi M; Ushio Y
Int J Mol Med; 1999 Feb; 3(2):157-61. PubMed ID: 9917523
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features.
Izumoto S; Suzuki T; Kinoshita M; Hashiba T; Kagawa N; Wada K; Fujimoto Y; Hashimoto N; Saitoh Y; Maruno M; Yoshimine T
Surg Neurol; 2005 Jun; 63(6):520-5; discussion 525. PubMed ID: 15936368
[TBL] [Abstract][Full Text] [Related]
3. [Craniopharyngioma with rapid regrowth--role of MIB-1 labeling index].
Anegawa S; Hayashi T; Nakagawa S; Furukawa Y; Tomokiyo M
No Shinkei Geka; 2001 Aug; 29(8):727-33. PubMed ID: 11554090
[TBL] [Abstract][Full Text] [Related]
4. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
[TBL] [Abstract][Full Text] [Related]
5. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
6. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children.
Raghavan R; Dickey WT; Margraf LR; White CL; Coimbra C; Hynan LS; Rushing EJ
Surg Neurol; 2000 Sep; 54(3):241-7; discussion 248. PubMed ID: 11118571
[TBL] [Abstract][Full Text] [Related]
8. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
[TBL] [Abstract][Full Text] [Related]
9. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer.
Suzuki M; Tsukagoshi S; Saga Y; Ohwada M; Sato I
Gynecol Oncol; 2000 Nov; 79(2):300-4. PubMed ID: 11063661
[TBL] [Abstract][Full Text] [Related]
10. Proliferation index determined by MIB-1 and recurrence in endometrial cancer.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
Gynecol Oncol; 1996 Jun; 61(3):373-7. PubMed ID: 8641618
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
12. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
Sakai K; Hongo K; Tanaka Y; Nakayama J
Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas.
Tena-Suck ML; Salinas-Lara C; Arce-Arellano RI; Rembao-Bojórquez D; Morales-Espinosa D; Sotelo J; Arrieta O
Clin Neurol Neurosurg; 2006 Oct; 108(7):661-9. PubMed ID: 16500745
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
16. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
17. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix.
Ho DM; Hsu CY; Chiang H
Gynecol Oncol; 2000 Jan; 76(1):97-102. PubMed ID: 10620448
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
[TBL] [Abstract][Full Text] [Related]
20. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence].
Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]